fluconazole has been researched along with Toxoplasmosis, Cerebral in 2 studies
Fluconazole: Triazole antifungal agent that is used to treat oropharyngeal CANDIDIASIS and cryptococcal MENINGITIS in AIDS.
fluconazole : A member of the class of triazoles that is propan-2-ol substituted at position 1 and 3 by 1H-1,2,4-triazol-1-yl groups and at position 2 by a 2,4-difluorophenyl group. It is an antifungal drug used for the treatment of mucosal candidiasis and for systemic infections including systemic candidiasis, coccidioidomycosis, and cryptococcosis.
Toxoplasmosis, Cerebral: Infections of the BRAIN caused by the protozoan TOXOPLASMA gondii that primarily arise in individuals with IMMUNOLOGIC DEFICIENCY SYNDROMES (see also AIDS-RELATED OPPORTUNISTIC INFECTIONS). The infection may involve the brain diffusely or form discrete abscesses. Clinical manifestations include SEIZURES, altered mentation, headache, focal neurologic deficits, and INTRACRANIAL HYPERTENSION. (From Joynt, Clinical Neurology, 1998, Ch27, pp41-3)
| Excerpt | Relevance | Reference |
|---|---|---|
| "In this study, the effects of the treatment with different doses of fluconazole (FLZ) in combination with the current treatment of acute toxoplasmosis on reducing the mortality rate and the parasitic load in the murine model in vivo were studied." | 1.62 | Determination of parasitic burden in the brain tissue of infected mice in acute toxoplasmosis after treatment by fluconazole combined with sulfadiazine and pyrimethamine. ( Anita, M; Hadi, M; Mohammad, JM; Reza, S; Sina, S; Soudabeh, E, 2021) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sina, S | 1 |
| Mohammad, JM | 1 |
| Reza, S | 1 |
| Anita, M | 1 |
| Soudabeh, E | 1 |
| Hadi, M | 1 |
| Sakamoto, N | 1 |
| Maeda, T | 1 |
| Mikita, K | 1 |
| Kato, Y | 1 |
| Yanagisawa, N | 1 |
| Suganuma, A | 1 |
| Imamura, A | 1 |
| Nakamura-Uchiyama, F | 1 |
| Miyahira, Y | 1 |
| Kawana, A | 1 |
| Ohnishi, K | 1 |
| Ajisawa, A | 1 |
2 other studies available for fluconazole and Toxoplasmosis, Cerebral
| Article | Year |
|---|---|
Determination of parasitic burden in the brain tissue of infected mice in acute toxoplasmosis after treatment by fluconazole combined with sulfadiazine and pyrimethamine.
Topics: 14-alpha Demethylase Inhibitors; Acute Disease; Animals; Antiprotozoal Agents; Brain; Disease Models | 2021 |
Clinical presentation and diagnosis of toxoplasmic encephalitis in Japan.
Topics: Acquired Immunodeficiency Syndrome; Adult; Antifungal Agents; Antiprotozoal Agents; Brain; Central N | 2014 |